Recently published in May 2014 through Academic Press/Elsevier.

A multi-contributor book written to teach, train and inspire entrepreneurs, managers and biotechnology industry professionals

Table of Contents

CHAPTER 1: Unleashing the Promise of Biotechnology to Help Heal, Fuel, and Feed the World
– James C. Greenwood

CHAPTER 2: A Biotechnology Entrepreneur’s Story: Advice to Future Entrepreneurs
– Henri A. Termeer

CHAPTER 3: The Biotechnology Industry: An Engine of Innovation

– G. Steven Burrill

CHAPTER 4: What is Biotechnology Entrepreneurship?

– Craig Shimasaki, PhD, MBA

CHAPTER 5: Five Essential Elements for Growing Biotechnology Clusters
– Craig Shimasaki, PhD, MBA

CHAPTER 6: Characteristics of Successful Biotechnology Leaders
– Lynn Johnson Langer, PhD, MBA

CHAPTER 7: Building, Managing, and Motivating Great Teams

– Arthur A. Boni, PhD, Laurie R. Weingart, PhD and Gergana Todorova, PhD

CHAPTER 8: Building Human Relationship Networks

– Tom D. Walker

CHAPTER 9: Understanding Biotechnology Product Sectors
 –  Craig Shimasaki, PhD, MBA

CHAPTER 10: Technology Opportunities: Evaluating the Idea
– Craig Shimasaki, PhD, MBA

CHAPTER 11: Commercialization of Bioagricultural Products

– Neal Gutterson, PhD

CHAPTER 12: Understanding Biotechnology Business Models and Managing Risk
– Craig Shimasaki, PhD, MBA

CHAPTER 13: Company Formation, Ownership Structure, and Securities Issues
– Craig C. Bradley, JD

CHAPTER 14: Licensing the Technology: Biotechnology Commercialization Strategies Using University and Federal Labs
– Stephen M. Ferguson, CLP and Uma S. Kaundinya, PhD, CLP

CHAPTER 15: Intellectual Property Protection Strategies for Biotechnology Innovations
– Gerry J. Elman, MS, JD and Jay Z. Zhang, MS, JD

CHAPTER 16: Biotechnology Products and Their Customers: Developing a Successful Market Strategy
– Craig Shimasaki, PhD, MBA

CHAPTER 17: Biotechnology Product Coverage, Coding and Reimbursement Strategies

– Robert E. Wanerman, JD, MPH and Susan Garfield, DrPH

CHAPTER 18: Getting the Word Out: Using Public Relations 
Strategies to Support Biotechnology Business Goals
– Joan E. Kureczka, MSEM

CHAPTER 19: Sources of Capital and Investor Motivations
 –  Craig Shimasaki, PhD, MBA

CHAPTER 20: Securing Angel Capital and Understanding How Angel Networks Operate
– Robert J. Calcaterra, DSc

CHAPTER 21: Understanding and Securing Venture Capital
–  Craig Shimasaki, PhD, MBA

CHAPTER 22: Your Business Plan and Presentation: Articulating Your Journey to Commercialization
– Lowell W Busenitz, PhD, MBA

CHAPTER 23: Therapeutic Drug Development and Human Clinical Trials
– Donald R. Kirsch, PhD

CHAPTER 24: Development and Commercialization of InVitro Diagnostics: Applications for Companion Diagnostics
– John F. Beeler, PhD

CHAPTER 25: Regulatory Approval and Compliances For Biotechnology Products
– Noman W. Baylor, PhD

CHAPTER 26: The Biomanufacturing of Biotechnology Products
– John Conner, MS, Don Wuchterl, Maria Lopez, Bill Minshall, MS, Rabi Prusti, PhD, Dave Boclair, Jay Peterson, Chris Allen, MS

CHAPTER 27: Company Growth Stages and the Value of Corporate Culture

– Craig Shimasaki, PhD, MBA

CHAPTER 28: Biotechnology Business Development: The Art of the Deal

– Jack M. Anthony and Phil Haworth, PhD, JD

CHAPTER 29: Biotech-Pharma Collaboration – A Strategic Tool: Case Study of Centocor
 –  Lara V. Marks, D.Phil. (Oxon)

CHAPTER 30: Ethical Considerations for Biotechnology Entrepreneurs
– Gladys B. White, PhD

CHAPTER 31: Career Opportunities in the Life Sciences Industry

– Toby Freedman, PhD

CHAPTER 32: Summary
– Craig Shimasaki, PhD, MBA

Contributors:

Chris Allen, MS Senior Manager Facilities and Engineering, Cytovance Biologics Inc., Oklahoma City, Oklahoma

Jack M. Anthony Founder and Principal, BioMentorz, Inc., Healdsburg, California

Norman W. Baylor, PhD President & CEO, Biologics Consulting Group, Inc., Alexandria, Virginia

John F. Beeler, PhD Director, Theranostics and Business Development bioMerieux, Cambridge, Massachusetts

Dave Boclair Manager Manufacturing Downstream Operations, Cytovance Biologics Inc., Oklahoma City, Oklahoma

Arthur A. Boni, PhD John R. Thorne Distinguished Career Professor of Entrepreneurship, Tepper School of Business at Carnegie Mellon University, Pittsburgh, Pennsylvania

Craig C. Bradley, JD Partner, Edwards Wildman Palmer LLP, Chicago, Illinois

G. Steven Burrill CEO, Burrill & Company, San Francisco, California

Lowell W. Busenitz, PhD, MBA Academic Director, Price College Center for Entrepreneurship, University of Oklahoma, Norman, Oklahoma

Robert J. Calcaterra, DSC President, St. Louis Arch Angels, St. Louis, Missouri

John Conner, MS Vice President Manufacturing Science and Technology, Cytovance Biologics, Inc., Oklahoma City, Oklahoma

Gerry J. Elman, MS, JD Elman Technology Law, P.C., Swarthmore, Pennsylvania

Steven M. Ferguson, CLP Deputy Director, Licensing & Entrepreneurship, Office of Technology Transfer, National Institutes of Health, Rockville, Maryland

Toby Freedman, PhD President, Synapsis Search Recruiting, Portolavalley, California

Susan Garfield, DrPH Senior Vice President, GfK Custom Research LLC, Wayland, Massachusetts

James C. Greenwood President & CEO, Biotechnology Industry Organization (BIO), Washington, D.C.

Neal Gutterson, PhD President & CEO, Mendel Biotechnology, Hayward, California

Phil Haworth, PhD, JD Principal, Biomentorz, Inc. Redwood City, California

Uma S. Kaundinya, PhD, CLP President & CEO, Aavishkar Innovations Inc., Bedford, Massachusetts

Donald R. Kirsch, PhD Chief Scientific Officer, Cambria Pharmaceuticals, Cambridge, Massachusetts

Joan E. Kureczka, MSEM Founder and Principal, Kureczka/Martin Associates and The Vivant Group, San Francisco, California

Lynn Johnson Langer, PhD, MBA Director, Enterprise and Regulatory Science Programs Center for Biotechnology Education, Johns Hopkins University, Rockville, Maryland

Maria Lopez Vice President Quality Systems, Cytovance Biologics Inc., Oklahoma City, Oklahoma

Lara V. Marks, D.Phil. (Oxon) Senior Research Fellow, Department of Social Science, Health and Medicine, King’s College, London, England

Bill Minshall, MS Senior Vice President Regulatory Affairs, Cytovance Biologics Inc., Oklahoma City, Oklahoma

Jay Peterson Manager Manufacturing Upstream Operations, Cytovance Biologics Inc., Oklahoma City, Oklahoma

Rabi Prusti, PhD Executive Director Quality Control, Cytovance Biologics Inc., Oklahoma City, Oklahoma

Craig Shimasaki, PhD, MBA President & CEO, Moleculera Labs and BioSource Consulting Group, Oklahoma City, Oklahoma

Henri A. Termeer Former Chairman, CEO and President of Genzyme Corporation, Cambridge, Massachusetts

Gergana Todorova, PhD Assistant Professor, School of Business Administration, University of Miami, Coral Gables, Florida

Tom D. Walker CEO & President, TechColumbus, Inc., Columbus, Ohio

Robert E. Wanerman, JD, MPH Epstein Becker Green, P.C., Washington, D.C.

Laurie R. Weingart, PhD Carnegie Bosch Professor of Organizational Behavior and Theory, Tepper School of Business at Carnegie Mellon University, Pittsburgh, Pennsylvania

Gladys B. White, PhD Adjunct Professor of Liberal Studies, Georgetown University, Washington, D.C.

Don Wuchterl Senior Vice President Operations, Cytovance Biologics Inc., Oklahoma City, Oklahoma

Jay Z. Zhang, MS, JD Shuwen Biotech Co. Ltd., Deqing, Zhejiang Province, China and Momentous IP Ventures LLC, Salt Lake City, Utah

Biotechnology Entrepreneurship Book
Buy on amazon